A man who shipped counterfeit cancer drugs to Houston was sentenced to 43 months in federal prison after pleading guilty to ...

As expiration dates for key patents approach, the blockbuster cancer drug pembrolizumab (Keytruda) reigned as the biggest pharma moneymaker one more time, edging out the diabetes/weight-loss drug ...

A 45-year-old man has been sentenced to prison for his role in selling tens of thousands of dollars' worth of counterfeit ...

The U.S. Food and Drug Administration on ‌Thursday approved Johnson & Johnson's treatment for a type of blood cancer, making ...

Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...

Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.

A Massachusetts federal court has sentenced an Indian national to more than three years in prison after he admitted to ...

Long-term use of proton pump inhibitors (PPIs) did not appear to be associated with an increased risk of gastric cancer, according to a population-based case-control study in five Nordic countries.